Literature DB >> 21617634

Measles: United States, January--May 20, 2011.

.   

Abstract

Measles is a highly contagious, acute viral illness that can lead to serious complications and death. Endemic or sustained measles transmission has not occurred in the United States since the late 1990s, despite continued importations (1). During 2001--2008, a median of 56 (range: 37--140) measles cases were reported to CDC annually (2); during the first 19 weeks of 2011, 118 cases of measles were reported, the highest number reported for this period since 1996. Of the 118 cases, 105 (89%) were associated with importation from other countries, including 46 importations (34 among U.S. residents traveling abroad and 12 among foreign visitors). Among those 46 cases, 40 (87%) were importations from the World Health Organization (WHO) European and South-East Asia regions. Of the 118, 105 (89%) patients were unvaccinated. Forty-seven (40%) patients were hospitalized and nine had pneumonia. The increased number of measles importations into the United States this year underscores the importance of vaccination to prevent measles and its complications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617634

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  20 in total

1.  The global dimensions of public health preparedness and implications for US action.

Authors:  Melinda Moore
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  "I've heard some things that scare me". Responding with empathy to parents' fears of vaccinations.

Authors:  Kenneth Holler; Anthony Scalzo
Journal:  Mo Med       Date:  2012 Jan-Feb

3.  Willingness to receive a hypothetical avian influenza vaccine among US military personnel in mid-deployment.

Authors:  Chad K Porter; Gina Fitamaurice; David R Tribble; Adam W Armstrong; Manal Mostafa; Mark S Riddle
Journal:  Hum Vaccin Immunother       Date:  2013-08-05       Impact factor: 3.452

4.  MMR Vaccine: When Is the Right Time for the Second Dose?

Authors:  Oscar R Herrera; Terrika A Thornton; Richard A Helms; Stephan L Foster
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

Review 5.  The globalization of risk and risk perception: why we need a new model of risk communication for vaccines.

Authors:  Heidi Larson; Pauline Brocard Paterson; Ngozi Erondu
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

6.  Validity of medical record documented varicella-zoster virus among unvaccinated cohorts.

Authors:  Salini Mohanty; Dana Perella; Aisha Jumaan; Donovan Robinson; Christine M Forke; D Scott Schmid; Mia Renwick; Foram Mankodi; Barbara Watson; Alexander G Fiks
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

7.  Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Megan M O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-20       Impact factor: 3.641

Review 8.  Spread of Measles in Europe and Implications for US Travelers.

Authors:  Kristina M Angelo; Paul A Gastañaduy; Allison T Walker; Manisha Patel; Susan Reef; C Virginia Lee; Jeffrey Nemhauser
Journal:  Pediatrics       Date:  2019-06-17       Impact factor: 7.124

9.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

Authors:  Nancy Bunin; Trudy Small; Paul Szabolcs; K Scott Baker; Michael A Pulsipher; Troy Torgerson
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-17       Impact factor: 5.742

Review 10.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.